Release Date: 27/02/14 17:06 Summary: Appendix 4D - Half Year Report Price Sensitive: Yes Download Document 637.6KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling